Iradimed (IRMD) to Release Quarterly Earnings on Thursday

Iradimed (NASDAQ:IRMD) will be posting its quarterly earnings results before the market opens on Thursday, October 31st. Analysts expect Iradimed to post earnings of $0.35 per share for the quarter. Iradimed has set its FY 2024 guidance at 1.520-1.620 EPS and its Q3 2024 guidance at 0.380-0.410 EPS.

Iradimed (NASDAQ:IRMD) last posted its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $0.38 EPS for the quarter, beating the consensus estimate of $0.33 by $0.05. The firm had revenue of $17.93 million during the quarter, compared to the consensus estimate of $17.70 million. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. During the same period in the prior year, the business earned $0.33 EPS. On average, analysts expect Iradimed to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Iradimed Stock Up 0.0 %

IRMD opened at $50.51 on Friday. The business has a 50 day moving average price of $48.24 and a two-hundred day moving average price of $45.14. The company has a market cap of $639.66 million, a PE ratio of 35.82 and a beta of 0.79. Iradimed has a 52 week low of $38.67 and a 52 week high of $52.45.

Iradimed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Tuesday, August 20th were paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date of this dividend was Tuesday, August 20th. Iradimed’s dividend payout ratio (DPR) is 42.55%.

Analyst Ratings Changes

Separately, Roth Mkm cut their target price on Iradimed from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, August 2nd.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.